THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

CEO of Biogen Idec to retire

Departure unrelated to Icahn, spokesman says

James C. Mullen joined Biogen Inc. in 1989. James C. Mullen joined Biogen Inc. in 1989. (Pat Greenhouse/ Globe Staff/ File 2006)
By Robert Gavin
Globe Staff / January 5, 2010

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

James C. Mullen, who battled with billionaire investor Carl Icahn over the direction and future of Biogen Idec Inc. , will retire as chief executive of the Cambridge biotechnology firm in June, the company announced yesterday. (Full article: 567 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass